Arnaud Scherpereel, Aaron S. Mansfield, Francesco Grossi, Sanjay Popat, Paul Baas, Anna K. Nowak, Anne S. Tsao, Nobukazu Fujimoto, Solange Peters, Yolanda Bautista Aragon, Toby Talbot, Dariusz Kowalski, Muhammet A. Kaplan, Andrés Felipe Cardona, Raheela Soomro, Nan Hu, Adam Lee, Virginia Ip, Yu-Han Hung, Gérard Zalcman. "Reply to: “Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743” and “Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743”." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco-26-01153